Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 4/20 | 0.47 |
| ▸ | ESR1 | P03372 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | JAK2 | O60674 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | DHFR | P00374 | 1/20 | 0.41 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28590274 | 1.00 | ESR2 (0.47) | ESR2ESR1ALDH1A1ALOX5JAK2 | |
| SCHEMBL19283276 | 0.98 | ESR2 (0.46) | ESR2ESR1ALDH1A1ALOX5JAK2 | |
| SCHEMBL28085916 | 0.98 | ESR2 (0.46) | ESR2ESR1ALDH1A1ALOX5JAK2 | |
| SCHEMBL21435747 | 0.98 | ESR2 (0.46) | ESR2ESR1ALDH1A1ALOX5JAK2 | |
| SCHEMBL2964995 | 0.98 | ESR2 (0.46) | ESR2ESR1ALDH1A1ALOX5JAK2 | |
| SCHEMBL5599347 | 0.98 | ESR2 (0.46) | ESR2ESR1ALDH1A1ALOX5JAK2 | |
| SCHEMBL994958 | 0.95 | ACHE (0.45) | ESR2ESR1ALDH1A1ALOX5JAK2 | |
| SCHEMBL29662092 | 0.95 | ACHE (0.45) | ESR2ESR1ALDH1A1ALOX5JAK2 | |
| SCHEMBL21332240 | 0.93 | ESR1 (0.43) | ESR2ESR1ALDH1A1ALOX5JAK2 | |
| SCHEMBL29541990 | 0.93 | ESR1 (0.43) | ESR2ESR1ALDH1A1ALOX5JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8293381-B2 | excellent power and luminance efficiencies in conjunction with a long service life; 2,7,9,10-tetraphenylanthracene | SFC CO., LTD. (KR) | 2012-10-23 | — | — | US | disclosed |
| US-20080152950-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SFC CO., LTD. (KR) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080152950-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | C1S, C1R, AOC2 | ESR2 1252/4885ESR1 339/4885ALDH1A1 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.